We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
A series of proprietary cell therapy programs for co-development or licensing
C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem......
15 April, 2019 News Press
This new explainer video provides a quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell therapy....
12 April, 2019 News Video
“Four months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office Aquitaine Science Transfert to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the ENSTBB, on the campus of Bordeaux, the start-up aims at providing the......
25 March, 2019 Events News Press VideoI am test text for Image with text shortcode. |
TreeFrog Therapeutics is a French stem cell company aiming at supporting the advent and industrial development of stem cell therapies.